A phase II study of biweekly pemetrexed (PEM) and gemcitabine (GEM) in patients (PTS) with metastatic breast cancer (MBC)
ANNALS OF ONCOLOGY(2006)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined